Crystallization and crystallographic analysis of an Arabidopsis nuclear proteinaceous RNase P by Pinker, F. (Franziska) et al.
research communications
1372 http://dx.doi.org/10.1107/S2053230X15017033 Acta Cryst. (2015). F71, 1372–1377
Received 24 July 2015
Accepted 11 September 2015
Edited by T. Bergfors, Uppsala University,
Sweden
Keywords: RNase P; nuclear PRORP; PPR;
tRNA maturation enzyme.
Crystallization and crystallographic analysis of an
Arabidopsis nuclear proteinaceous RNase P
Franziska Pinker,a,b Philippe Giege´b and Claude Sautera*
aUPR 9002 du CNRS, IBMC, Centre National de la Recherche Scientifique, University of Strasbourg, 15 Rue Rene´
Descartes, 67084 Strasbourg, France, and bUPR 2357 du CNRS, IBMP, Centre National de la Recherche Scientifique,
University of Strasbourg, 12 Rue du Ge´ne´ral Zimmer, 67084 Strasbourg, France. *Correspondence e-mail:
c.sauter@ibmc-cnrs.unistra.fr
RNase P activity is ubiquitous and involves the 50 maturation of precursor
tRNAs. For a long time, it was thought that all RNases P were ribonucleoproteic
enzymes. However, the characterization of RNase P in human mitochondria and
in plants revealed a novel kind of RNase P composed of protein only, called
PRORP for ‘proteinaceous RNase P’. Whereas in human mitochondria PRORP
has two partners that are required for RNase P activity, PRORP proteins are
active as single-subunit enzymes in plants. Three paralogues of PRORP are
found in Arabidopsis thaliana. PRORP1 is responsible for RNase P in
mitochondria and chloroplasts, while PRORP2 and PRORP3 are nuclear
enzymes. Here, the purification and crystallization of the Arabidopsis PRORP2
protein are reported. Optimization of the initial crystallization conditions led to
crystals that diffracted to 3 A˚ resolution.
1. Introduction
RNase P is the universal enzyme catalyzing the maturation of
precursor 50-ends of transfer RNAs (tRNAs), as well as many
other substrates such as ribosomal RNA, messenger RNA,
transfer-messenger RNA and riboswitches (Hartmann &
Hartmann, 2003; Lai et al., 2010). It was first described in
bacteria as a ribonucleoprotein (RNP) complex, in which
the RNA component (P RNA) possesses the catalytic activity
(Guerrier-Takada et al., 1983). Since RNP RNase P was
subsequently found in all three domains of life, i.e. bacteria,
archaea and eukarya, it was believed to be a universally
conserved RNP complex (Altman, 2007). However, early
experiments in spinach chloroplasts and subsequently in
human mitochondria suggested the existence of a proteinac-
eous type of RNase P that lacks an essential RNA component
(Wang et al., 1988; Rossmanith & Karwan, 1998; Pinker et al.,
2013). In 2008, Rossmanith and coworkers demonstrated by
recombinant expression of human mitochondrial RNase P in
Escherichia coli that it is a complex of three protein subunits
with no RNA component (Holzmann et al., 2008). In Arabi-
dopsis this novel variant is composed of single proteins with
RNase P activity that were named PRORP (for proteinaceous
RNase P; Gobert et al., 2013).
The discovery of PRORP enzymes led to the question
whether the RNP and protein enzymes have evolved different
modes of action to catalyze the same reaction. Biophysical and
crystallographic studies of Arabidopsis PRORP enzymes have
recently shown that they consist of two main domains: an
N-terminal pentatricopeptide-repeat (PPR) domain and a
C-terminal catalytic metallonuclease domain linked by a zinc-
binding module (Fig. 1; Gobert et al., 2010; Howard et al.,
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2012). The PPR domain confers RNA binding and substrate
specificity and consists of five PPR motifs folded into a pair of
antiparallel -helices (Giege´, 2013). The most conserved part
of the PRORP enzymes is their C-terminal metallonuclease
domain, which belongs to the large family of NYN (N4BP1,
YacP-like nuclease) ribonucleases (Anantharaman &
Aravind, 2006). The crystal structure of A. thaliana PRORP1
(AtPRORP1) revealed the presence of two magnesium ions
that are bound to conserved Asp residues of the NYN
metallonuclease domain and are involved in catalysis.
PRORP1 is an organellar enzyme that is active both in
mitochondria and chloroplasts (Gobert et al., 2010). Arabi-
dopsis also expresses two closely related paralogues,
AtPRORP2 and AtPRORP3, that are responsible for tRNA
maturation in the nucleus.
In order to obtain deeper insights into the diversity of
function and structural organization of PRORP enzymes, we
initiated the crystallographic characterization of a nuclear
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Figure 1
Alignment of the genomic sequences of PRORP1, PRORP2 and PRORP3 from A. thaliana. The organellar PRORP1 shares 47% identity with either of
the two nuclear forms, while the nuclear PRORP2 and PRORP3 share 80% identity with each other. The secondary structures observed in the PRORP1
X-ray structure (PDB entry 4g26) are displayed. The crystallized PRORP1 construct was deprived of its N-terminal organellar targeting sequence and
started at residue 92. The full-length PRORP2 construct used in this work started with MGA (instead of MA) and contained a C-terminal affinity tag
(see x2). The PPR (RNA-binding) domain, the NYN metallonuclease (catalytic) domain and the bipartite zinc-binding module (Cys/His residues
involved in zinc coordination are marked with asterisks) are indicated. This figure was prepared using ESPript (Robert & Gouet, 2014).
proteinaceous RNase P. The purification and crystallization of
the nuclear AtPRORP2 protein are reported. Optimization
of the initial crystallization conditions led to crystals that
diffracted to 3 A˚ resolution.
2. Materials and methods
2.1. Macromolecule production
The full length cDNA of AtPRORP2 (NCBI reference
sequence NP_179256) was cloned from the Arabidopsis
transcriptome into pET-28b(+) vector (Novagen) coding for a
C-terminal His6 tag. Owing to cloning, one additional
N-terminal amino acid (MGA instead of MA) and two addi-
tional amino acids (LE) upstream of the His tag were intro-
duced, resulting in a protein of 537 amino acids (Fig. 1).
Escherichia coli BL21 (DE3) cells transformed with pET-28-
PRORP2 were grown at 310 K in LB medium containing
50 mg ml1 kanamycin until the OD600 nm reached 0.7. Protein
was expressed overnight at 291 K in LB medium with a final
concentration of 0.5 mM IPTG. The E. coli cells were
harvested and the pellet was stored at 253 K until purification.
1 g of cells was lysed in 10 ml Ni–NTA buffer A [50 mM
HEPES–Na pH 7.5, 250 mM NaCl, 5%(w/v) glycerol, 5 mM
imidazole, 10 mM -mercaptoethanol] and protease-inhibitor
cocktail (Sigma, catalogue No. S8830; one tablet per 100 ml)
with ten cycles of 30 s sonication (followed by 60 s on ice). The
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Figure 2
PRORP2 purification and quality control. (a) Elution profile of full-length PRORP2 during size-exclusion chromatography (SEC). (b) Coomassie-
stained 8% SDS–PAGE of PRORP2. Lane L, molecular-weight ladder (labelled in kDa); lanes 6–11, fractions from SEC. Fractions 9 and 10 were pooled
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Ni–NTA resin (Sigma, catalogue No. H0537) was equilibrated
with buffer A. The protein was loaded at 1 ml min1 and was
sequentially washed with ten column volumes at 2 ml min1
with increasing imidazole concentrations (steps at 5, 10 and
15 mM). The protein was eluted with 2.5 column volumes of
buffer A supplemented with 250 mM imidazole at 2 ml min1.
Fractions containing the protein were pooled, concentrated
in SEC buffer [50 mM HEPES–Na pH 7.5, 250 mM NaCl,
15%(w/v) glycerol, 1 mM TCEP] on a cellulose membrane
(30K MWCO, Amicon Ultra, Millipore) and further purified
using size-exclusion chromatography at 0.5 ml min1 on a
Superdex 200 10/300 GL (GE Healthcare) column equili-
brated with SEC buffer (Fig. 2a). Fractions containing
PRORP2 were concentrated, ultracentrifuged and stored at
277 K until use. The average purification yield was about 1 mg
of pure AtPRORP2 per gram of host cells. Sample purity and
homogeneity were assessed by Coomassie-stained SDS–
PAGE (Fig. 2b) and dynamic light scattering at 293 K (Fig. 2c)
after ultracentrifugation (1 h, 105g, 277 K) using a Zetasizer
NanoSeries Nano-S instrument (Malvern). Macromolecule-
production information is summarized in Table 1.
2.2. Crystallization
The search for crystallization conditions was carried out by
vapour diffusion using a Mosquito Crystal pipetting robot
(TTP Labtech, UK) and 96-well sitting-drop plates (CrystalEx
microplate, conical flat bottom, five subwells, Corning). Initial
screening was performed with PRORP2 at 5–10 mg ml1 in
SEC buffer. This concentration turned out to be excessive
because the protein precipitated in many drops. Further
experiments were performed at 2–5 mg ml1 and the SEC
buffer was modified to contain only 5%(w/v) glycerol instead
of 15%(w/v). Different screens were tested by mixing 150 nl
protein solution with 150 nl crystallant solution and equili-
brating at 277 and 293 K over a reservoir containing 35 ml
crystallant solution. The tested screens were JCSG+, Clear
Strategy Screen 1, Morpheus (Molecular Dimensions), Magic1
and Magic2 (MPI, Martinsried, Germany), PEG/Ion
(Hampton Research) and Wizard I and II (Emerald Bio). The
experiments for optimization were set up manually as micro-
batch experiments in Terazaki microplates (Greiner Bio-One,
catalogue No. 653 102) or as hanging drops in 24-well Linbro
plates (Hampton Research) by mixing the protein and crys-
tallant solutions in ratios of 1:1 or 2:1 with total volumes of
2 and 3 ml, respectively. Various crystallant and protein
concentrations, as well as additives and different temperatures
(277 and 293 K), were tested. Crystallization information is
summarized in Table 2.
2.3. Data collection and processing
For diffraction experiments, crystals were mounted in nylon
loops with a diameter of 200 mm (Hampton Research, USA),
flash-cooled in the mother liquor and stored in liquid nitrogen.
Two diffraction data sets were collected from independent
crystals at 100 K with a wavelength of 1 A˚ using a PILATUS
2M detector at a crystal-to-detector distance of 300 mm on the
X06DA beamline at the SLS, PSI, Villigen, Switzerland.
Diffraction images were processed using the XDS package
(Kasbch, 2010) and data-collection statistics are summarized
in Table 3. The solvent content was estimated using the CCP4
package and the self-rotation function was analyzed with
GLRF (Winn et al., 2011; Tong & Rossmann, 1997).
3. Results and discussion
Full-length PRORP2 including its N-terminal nuclear locali-
zation sequence and a C-terminal His tag (Fig. 1) was
expressed in E. coli and purified to homogeneity using affinity
and size-exclusion chromatography. Analysis of pure
PRORP2 by DLS indicated that the protein was stable,
homogeneous and monodisperse in solution, with a hydro-
dynamic radius of 4.5 nm (Fig. 2).
Initial crystallization screening was carried out with
PRORP2 (5–10 mg ml1) in SEC buffer at 293 K, and yielded
many precipitated drops but no crystal-like hits. We therefore
research communications




Plate type Terazaki microplates (Greiner
Bio-One, catalogue No. 653 102)
Temperature (K) 277
Protein stock concentration (mg ml1) 2.5
Buffer composition of protein solution 50 mM HEPES–Na pH 7.5, 250 mM
NaCl, 5%(w/v) glycerol, 1 mM
TCEP
Crystallant solution 200 mM sodium malonate pH 6,
20% PEG 3350
Drop volume and mixing ratio 2 ml, 1:1
Table 3
Data collection and processing.
Values in parentheses are for the outer shell.
Crystal 1 2
Diffraction source X06DA, SLS X06DA, SLS
Wavelength (A˚) 1.0 1.0
Temperature (K) 100 100
Detector PILATUS 2M PILATUS 2M
Crystal-to-detector distance (mm) 300 300
Rotation range per image () 0.25 0.25
Total rotation range () 360 360
Exposure time per image (s) 0.25 0.25
Space group P1 P1
a, b, c (A˚) 70.5, 72.8, 80.3 68.1, 72.5, 80.4
, ,  () 63.1, 72.3, 78.4 63.1, 71.8, 77.3
Mosaicity () 0.62 0.29
Resolution range (A˚) 50–3.0 (3.19–3.00) 50–3.2 (3.39–3.20)
Total No. of reflections 88462 (15571) 74751 (12431)
No. of unique reflections 25055 (4252) 21035 (3395)
Completeness (%) 92.4 (96.7) 97.7 (98.2)
Multiplicity 3.5 (3.7) 3.2 (3.3)
hI/(I)i 8.2 (0.8) 8.8 (1.0)
Rmeas (%) 14.4 (215) 15.0 (162)
CC1/2 (%) 99.8 (36.0) 99.7 (45.6)
Overall B factor from Wilson plot (A˚2) 90.3 89.0
Matthews coefficient (A˚3 Da1) 2.9 2.8
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changed the protein storage buffer and reduced the glycerol
concentration from 15 to 5%(w/v) to favour crystallization.
We also set up all screens at two temperatures: 277 and 293 K.
Small intertwined plate-like crystals were obtained after
several days at 277 K in condition E6 of the PEG/Ion screen
(Hampton Research). The presence of PRORP2 in the crys-
tals was assessed using SDS–PAGE and mass spectrometry
(result not shown). The initial crystals diffracted to 7 A˚ reso-
lution, but the data could not be integrated. This condition,
consisting of 200 mM sodium malonate pH 6, 20%(w/v) PEG
3350, was used as a starting point for further optimization.
To decrease the number of crystals per drop and to favour
their growth in three dimensions, we performed grid
screening: the protein concentration was varied from 2 to
10 mg ml1, the PEG concentration from 16 to 25%(w/v) PEG
3350 and the salt concentration from 100 to 200 mM. Various
additives were tested using Additive Screen (Hampton
Research). The optimized conditions, which were initially
defined by vapour diffusion, were adapted to the batch
method to speed up crystal production. This did not change
the plate-like morphology of the crystals or their strong
tendency to grow in stacks (Fig. 3a). However, the largest
specimens could be separated using a cryoloop for flash-
cooling in liquid nitrogen and diffracted to 3 A˚ resolution.
Using the crystals shown in Fig. 3, with average dimensions of
200  100  10 mm, two complete monoclinic data sets were
collected. No twinning was detected in either data set. They
could not be merged owing to non-isomorphism. Estimation of
the solvent content (Table 3) and self-rotation function (Fig. 3)
analysis suggested the presence of two molecules in the
asymmetric unit related by a twofold noncrystallographic
symmetry axis. Molecular replacement with homology models
derived from the crystal structure of A. thaliana PRORP1
(PDB entry 4g26; Howard et al., 2012) is in progress.
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